US 12186282
Treatment of 22Q11.2 deletion syndrome with cannabidiol
granted A61KA61K31/035A61K31/658
Quick answer
US patent 12186282 (Treatment of 22Q11.2 deletion syndrome with cannabidiol) held by Harmony Biosciences Management, Inc. expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Harmony Biosciences Management, Inc.
- Grant date
- Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/035, A61K31/658, A61K9/0014, A61K9/06